Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 1
2011 2
2012 2
2013 3
2014 4
2015 4
2016 4
2017 5
2018 4
2019 4
2020 8
2021 3
2022 6
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean huang hung tu (21 results)?
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.
Ahn MJ, Cho BC, Felip E, Korantzis I, Ohashi K, Majem M, Juan-Vidal O, Handzhiev S, Izumi H, Lee JS, Dziadziuszko R, Wolf J, Blackhall F, Reck M, Bustamante Alvarez J, Hummel HD, Dingemans AC, Sands J, Akamatsu H, Owonikoko TK, Ramalingam SS, Borghaei H, Johnson ML, Huang S, Mukherjee S, Minocha M, Jiang T, Martinez P, Anderson ES, Paz-Ares L; DeLLphi-301 Investigators. Ahn MJ, et al. Among authors: huang s. N Engl J Med. 2023 Nov 30;389(22):2063-2075. doi: 10.1056/NEJMoa2307980. Epub 2023 Oct 20. N Engl J Med. 2023. PMID: 37861218 Clinical Trial.
Epigenetics in ovarian cancer: premise, properties, and perspectives.
Yang Q, Yang Y, Zhou N, Tang K, Lau WB, Lau B, Wang W, Xu L, Yang Z, Huang S, Wang X, Yi T, Zhao X, Wei Y, Wang H, Zhao L, Zhou S. Yang Q, et al. Among authors: huang s. Mol Cancer. 2018 Jul 31;17(1):109. doi: 10.1186/s12943-018-0855-4. Mol Cancer. 2018. PMID: 30064416 Free PMC article. Review.
In this review, we summarize the most recent discoveries pertaining to ovarian cancer development arising from the imbalance of histone acetylation and methylation, and provide insight into novel therapeutic interventions for the treatment of ovarian carcinoma....
In this review, we summarize the most recent discoveries pertaining to ovarian cancer development arising from the imbalance of histone acet …
Transgelin-2 as a therapeutic target for asthmatic pulmonary resistance.
Yin LM, Xu YD, Peng LL, Duan TT, Liu JY, Xu Z, Wang WQ, Guan N, Han XJ, Li HY, Pang Y, Wang Y, Chen Z, Zhu W, Deng L, Wu YL, Ge GB, Huang S, Ulloa L, Yang YQ. Yin LM, et al. Among authors: huang s. Sci Transl Med. 2018 Feb 7;10(427):eaam8604. doi: 10.1126/scitranslmed.aam8604. Sci Transl Med. 2018. PMID: 29437149 Free PMC article.
TSG12 is more effective than beta(2)-agonists in relaxing human ASMCs and pulmonary resistance with potential clinical advantages. These results suggest that TSG12 could be a promising therapeutic approach for treating asthma....
TSG12 is more effective than beta(2)-agonists in relaxing human ASMCs and pulmonary resistance with potential clinical advantages. These res …
ROS-mediated SRMS activation confers platinum resistance in ovarian cancer.
Jiang Y, Song L, Lin Y, Nowialis P, Gao Q, Li T, Li B, Mao X, Song Q, Xing C, Zheng G, Huang S, Jin L. Jiang Y, et al. Among authors: huang s. Oncogene. 2023 May;42(20):1672-1684. doi: 10.1038/s41388-023-02679-6. Epub 2023 Apr 5. Oncogene. 2023. PMID: 37020040 Free PMC article.
Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment.
Geusens P, Bevers MS, van Rietbergen B, Messina OD, Lespessailles E, Oliveri B, Chapurlat R, Engelke K, Chines A, Huang S, Saag KG, van den Bergh JP. Geusens P, et al. Among authors: huang s. J Bone Miner Res. 2022 Jun;37(6):1136-1146. doi: 10.1002/jbmr.4551. Epub 2022 Apr 19. J Bone Miner Res. 2022. PMID: 35340062 Free PMC article. Clinical Trial.
To conclude, this HR-pQCT study shows that denosumab is superior to risedronate in terms of preventing FL loss at the distal radius and tibia in GC-I and in increasing FL at the radius in GC-C, based on significant differences in changes in the cortical and trabecular bone compar …
To conclude, this HR-pQCT study shows that denosumab is superior to risedronate in terms of preventing FL loss at the distal radius and tibi …
Role of urokinase receptor in tumor progression and development.
Noh H, Hong S, Huang S. Noh H, et al. Among authors: huang s. Theranostics. 2013 Jun 25;3(7):487-95. doi: 10.7150/thno.4218. Print 2013. Theranostics. 2013. PMID: 23843896 Free PMC article. Review.
The importance of uPAR's co-receptor in uPAR's tumor-promoting effects implicate that anti-cancer therapeutic agents may also be developed by disrupting the interactions between uPAR and its functional partners....
The importance of uPAR's co-receptor in uPAR's tumor-promoting effects implicate that anti-cancer therapeutic agents may also be deve …
Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness-adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension.
Hans D, McDermott M, Huang S, Kim M, Shevroja E, McClung M. Hans D, et al. Among authors: huang s. Osteoporos Int. 2023 Jun;34(6):1075-1084. doi: 10.1007/s00198-023-06708-8. Epub 2023 Mar 2. Osteoporos Int. 2023. PMID: 36862192 Free PMC article. Clinical Trial.
Bone Mineral Density After Transitioning From Denosumab to Alendronate.
Kendler D, Chines A, Clark P, Ebeling PR, McClung M, Rhee Y, Huang S, Stad RK. Kendler D, et al. Among authors: huang s. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e255-64. doi: 10.1210/clinem/dgz095. J Clin Endocrinol Metab. 2020. PMID: 31665314 Free PMC article. Clinical Trial.
56 results